Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors

Etoposide-loaded nanostructured lipid carriers for gastric cancer therapy

(2015) Hong Jiang et al.   DRUG DELIVERY

Improved oral bioavailability of valsartan using proliposomes: design, characterization andin vivopharmacokinetics

(2015) Vijaykumar Nekkanti et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity

(2015) Ruchi Singh et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

A comparative study of chitosan and poloxamer based thermosensitive hydrogel for the delivery of PEGylated melphalan conjugates

(2015) Amit Alexander et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Dissolution enhancement of curcuminviacurcumin–prebiotic inulin nanoparticles

(2015) Mohammad M. Fares et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Inhibition Against Growth of Glioblastoma Multiforme In Vitro Using Etoposide-Loaded Solid Lipid Nanoparticles with ρ-Aminophenyl-α-D-Manno-Pyranoside and Folic Acid

(2015) Yung-Chih Kuo et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Curcumin suppresses lymphatic vessel density in an in vivo human gastric cancer model

(2015) Wei Da et al.   TUMOR BIOLOGY

Improved tumor targetability of Tat-conjugated PAMAM dendrimers as a novel nanosized anti-tumor drug carrier

(2014) Chengyun Yan et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment

(2014) Xu Bao et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting

(2014) Omidreza Jafarieh et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Inhibition of β-catenin and STAT3 with a curcumin analog suppresses gastric carcinogenesis in vivo

(2014) Yoshihiko Uehara et al.   Gastric Cancer

Intracellular uptake of etoposide-loaded solid lipid nanoparticles induces an enhancing inhibitory effect on gastric cancer through mitochondria-mediated apoptosis pathway

(2014) Jiao Wang et al.   International Journal of Nanomedicine

Nanoemulsion Based Concomitant Delivery of Curcumin and Etoposide: Impact on Cross Talk Between Prostate Cancer Cells and Osteoblast During Metastasis

(2014) Prashant Shukla et al.   Journal of Biomedical Nanotechnology

Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: pharmacokinetics, cytotoxicity and cellular uptake studies

(2013) Jiawei Li et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Comparative characterization and cytotoxicity study of TAT-peptide as potential vectors for siRNA andDicer-substrate siRNA

(2013) Haliza Katas et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

5-Fluorouracil-loaded PLA/PLGA PEG–PPG–PEG polymeric nanoparticles: formulation,in vitrocharacterization and cell culture studies

(2013) Harika Öcal et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Development andin vitroevaluation of a nanoemulsion for transcutaneous delivery

(2013) Grace Ledet et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

The in vitro sustained release profile and antitumor effect of etoposide-layered double hydroxide nanohybrids

(2013) Lili Qin et al.   International Journal of Nanomedicine

Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development

(2013) Min-Yu Chung   WORLD JOURNAL OF GASTROENTEROLOGY

Colloidal formulations of etoposide based on poly(butyl cyanoacrylate) nanoparticles: Preparation, physicochemical properties and cytotoxicity

(2012) Georgi Yordanov et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Effect of intratumoral injection on the biodistribution and therapeutic potential of novel chemophor EL-modified single-walled nanotube loading doxorubicin

(2012) Hongzhuo Liu et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir

(2012) Ali Seyfoddin et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Formulation, characterization andin vitro–in vivoevaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery

(2012) Jitendra Kawadkar et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Gastric cancer epidemiology and risk factors

(2012) Douglas E. Guggenheim et al.   JOURNAL OF SURGICAL ONCOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Influence of acetazolamide loading on the (in vitro) performances of non-phospholipid-based cationic nanosized emulsion in comparison with phospholipid-based anionic and neutral-charged nanosized emulsions

(2011) Shunmugaperumal Tamilvanan et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide

(2011) Tiecheng Zhang et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles

(2010) Chunbai He et al.   BIOMATERIALS

Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil

(2010) Xiu-Li Zhao et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Oral solid compritol 888 ATO nanosuspension of simvastatin: optimization and biodistribution studies

(2010) Mayank Shah et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Etoposide Loaded PLGA and PCL Nanoparticles II: Biodistribution and Pharmacokinetics after Radiolabeling with Tc-99m

(2008) Movva Snehalatha et al.   DRUG DELIVERY